Birkhäuser, Martin

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | 2005

2013

Nedeljkovic, Marko; Tian, Li; Ji, Ping; Déglon-Fischer, Agnès; Stute, Petra; Ocon, Erika; Birkhäuser, Martin; Ausfeld-Hafter, Brigitte (2013). Effects of acupuncture and Chinese herbal medicine (Zhi Mu 14) on hot flushes and quality of life in postmenopausal women: results of a four-arm randomized controlled pilot trial. Menopause - the journal of the North American Menopause Society, 21(1), pp. 15-24. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/GME.0b013e31829374e8

2012

Lippuner, Kurt; Buchard, P A; De Geyter, C; Imthurn, B; Lamy, O; Litschgi, M; Luzuy, F; Schiessl, K; Stute, P; Birkhäuser, M (2012). Recommendations for raloxifene use in daily clinical practice in the Swiss setting. European spine journal, 21(12), pp. 2407-17. Berlin: Springer 10.1007/s00586-012-2404-y

Rohner, S; Birkhäuser, M; Santi, A; Mueller, MD; Kuhn, A (2012). Gynäkologische Probleme bei Transsexuellen: eine Analyse von 1956 Konsultationen. In: Jahreskongress SGGG , Interlaken 2012. Jahreskongress SGGG , Interlaken 2012

Birkhäuser, M; De Geyter, Ch; Finkenstedt, G; Hofbauer, L; Meier, C; Scharla, S; Stute, P; Ziller, V; Hadji, P (2012). Osteoporose: Phasengerechte Therapie & Neues aus der Zellbiologie. Journal für Mineralstoffwechsel : Zeitschrift für Knochen- und Gelenkserkrankunge, 19(1), pp. 42-6. Gablitz (A): Krause & Pachernegg

Birkhäuser, M; De Geyter, Ch; Finkenstedt, G; Hofbauer, L; Meier, C; Scharla, S; Stute, P; Ziller, V; Hadji, P (2012). Ostéoporose: traitements par stade & innovations en biologie cellulaire. Journal für gynäkologische Endokrinologie, 6(2), pp. 20-4. Gablitz (A): Krause & Pachernegg

Birkhäuser, M; De Geyter, Ch; Finkenstedt, G; Hofbauer, L; Meier, C; Scharla, S; Stute, P; Ziller, V; Hadji, P (2012). Osteoporose: Phasengerechte Therapie & Neues aus der Zellbiologie. Journal für gynäkologische Endokrinologie, 6(1), pp. 22-6. Gablitz (A): Krause & Pachernegg

Stute, P; Becker, HG; Birkhäuser, M; Bitzer, J; chatsiproios, D; Luzuy, F; von Wolff, M; Wunder, D (2012). Ultra-Low Dose – Neue Wege in der Hormontherapie. Journal für gynäkologische Endokrinologie, 6(3), pp. 20-3. Gablitz (A): Krause & Pachernegg

2011

Birkhäuser, M; Stute, P (2011). Editorial. Journal für gynäkologische Endokrinologie - Schweiz, 5(1), pp. 5-10. Gablitz (A): Krause & Pachernegg

Villena Ossa, T; Kuhn, A; Burckhardt, I; Bodmer, Ch; Birkhäuser, M (2011). Sexuelle Orientierung transsexuelle Patienten. In: Jahreskongress SGGG, Lugano 2011. Jahreskongress SGGG, Lugano 2011

Wunder, D; Birkhäuser, MH; Bersinger, NA (2011). Soluble HLA-G concentration in follicular fluid and embryo culture medium and its impact on prediction or pregnancy. In: Jahreskongress SGGG, Lugano 2011 28 (pp. 43-50). Jahreskongress SGGG, Lugano 2011 10.1016/j.immbio.2012.10.004

Wunder, D; Neurohr, EM; Faouzi, M; Birkhäuser, M (2011). Origin of multiple pregnancies in Berne, Switzerland, between 1995 and 2006: is IVF-ICSI really the most important origin? In: Jahreskongress SGGG, Lugano 2011. Jahreskongress SGGG, Lugano 2011

2009

Kuhn, Annette; Bodmer, Christine; Stadlmayr, Werner; Kuhn, Peter; Mueller, Michael D; Birkhäuser, Martin (2009). Quality of life 15 years after sex reassignment surgery for transsexualism. Fertility and sterility, 92(5), 1685-1689.e3. New York, N.Y.: Elsevier 10.1016/j.fertnstert.2008.08.126

2008

Bersinger, Nick A; Wunder, Dorothea M; Birkhäuser, Martin H; Mueller, Michael D (2008). Gene expression in cultured endometrium from women with different outcomes following IVF. Molecular human reproduction MHR, 14(8), pp. 475-84. Oxford: Oxford University Press 10.1093/molehr/gan036

Bersinger, N A; Wunder, D M; Nicolas, M; Birkhäuser, M H; Porquet, D; Guibourdenche, J (2008). Serum hyperglycosylated human chorionic gonadotropin to predict the gestational outcome in in vitro fertilization/intracytoplasmic sperm injection pregnancies. Fetal diagnosis and therapy, 24(1), pp. 74-8. Basel: Karger 10.1159/000132412

Wunder, Dorothea M; Guibourdenche, Jean; Birkhäuser, Martin H; Bersinger, Nick A (2008). Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection. Fertility and sterility, 90(6), pp. 2203-10. New York, N.Y.: Elsevier 10.1016/j.fertnstert.2007.10.078

Birkhäuser, M H; Panay, N; Archer, D F; Barlow, D; Burger, H; Gambacciani, M; Goldstein, S; Pinkerton, J A; Sturdee, D W (2008). Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric, 11(2), pp. 108-23. Abingdon, UK: Informa Healthcare 10.1080/13697130801983921

Pines, A; Sturdee, D W; Birkhauser, M H; de Villiers, T; Naftolin, F; Gompel, A; Farmer, R; Barlow, D; Tan, D; Maki, P; Lobo, R; Hodis, H (2008). HRT in the early menopause: scientific evidence and common perceptions. Climacteric, 11(4), pp. 267-72. Abingdon, UK: Informa Healthcare 10.1080/13697130802226866

Birkhäuser, M H; Reinecke, I (2008). Current trends in hormone replacement therapy: perceptions and usage. Climacteric, 11(3), pp. 192-200. Abingdon, UK: Informa Healthcare 10.1080/13697130802060455

Pines, Amos; Sturdee, David; Birkhäuser, Martin (2008). Health risks after cessation of postmenopausal hormone therapy. Climacteric, 11(3), pp. 179-80. Abingdon, UK: Informa Healthcare 10.1080/13697130802176228

Birkhauser, M; Braendle, W; Kiesel, L; Kuhl, H; Neulen, J; Thaler, C J (2008). [Recommendations for hormone treatment with estrogen and progesterone in the climacteric and postmenopausal periods. 37th Workshop of the Zurich Discussion Group , September 2006]. Gynäkologisch-geburtshilfliche Rundschau, 48(1), pp. 38-46. Basel: Karger

Birkhäuser, MH (2008). Östrogene zur Osteoporoseprävention. Was gilt 2008. Gynäkologie(1), pp. 2-6. Neuhausen (CH): Rosenfluh Publikationen

Pines, A; Sturdee, D; Birkhäuser, MH; de Villiers, T; Naftolin, F; Gompel, A; Farmer, R; Barlow, D; Tan, D; Maki, P; Lobo, R; Hordis, H (2008). Kongressbericht: HRT in der frühen Manopause: Wissenschaftliche Evidenz und allgemeine Wahrnehmung. Journal für gynäkologische Endokrinologie - Schweiz, 2(4), pp. 23-27. Gablitz (A): Krause & Pachernegg

Birkhäuser, MH (2008). Editorial. Gynäkologie(1), p. 1. Neuhausen (CH): Rosenfluh Publikationen

Birkhäuser, H (2008). Editorials. Journal für gynäkologische Endokrinologie - Schweiz, 2(1) Gablitz (A): Krause & Pachernegg

Birkhäuser, MH; Kuhl, H; Mück, O; Schaudig, K; Dierks, C (2008). 2008. Tinneberg: Commed Verlag

2007

Kuhn, Annette; Hiltebrand, Rahel; Birkhäuser, Martin (2007). Do transsexuals have micturition disorders? European journal of obstetrics & gynecology and reproductive biology, 131(2), pp. 226-30. Shannon: Elsevier 10.1016/j.ejogrb.2006.03.019

Kohler, C; Tschumi, K; Bodmer, C; Schneiter, M; Birkhäuser, M (2007). Effect of finasterid 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testoerone. Gynecological endocrinology, 23(3), pp. 142-145. London: Informa Healthcare 10.1080/09513590701214463

Birkhäuser, MH; Brändle, W; Keller, PJ; Kiesel, L; Kuhl, H; Neulen, J (2007). Empfehlungen zur Substitution mit Östrogenen und Gestagenen im Klimakterium und in der Postmenopause. Gynäkologisch-geburtshilfliche Rundschau(47), pp. 45-48. Basel: Karger

Birkhäuser, MH; Brändle, W; Keller, PJ; Kieser, L; Kuhl, H; Neulen, J (2007). Empfehlungen zur hormonalen Kontrazeption. Gynäkologisch-geburtshilfliche Rundschau(47), pp. 94-98. Basel: Karger

Birkhäuser, MH; Brändle, W; Kiesel, L; Kuhl, H; Neulen, J; Thaler, CJ (2007). Empfehlungen zur Hormonbehandlung mit Östrogenen und Gestagenen im Klimakterium und in der Postmenopause. Gynäkologisch-geburtshilfliche Rundschau(48), pp. 38-46. Basel: Karger

Birkhäuser, MH (2007). Editorial. Journal für gynäkologische Endokrinologie - Schweiz, 1(1), pp. 4-7. Gablitz (A): Krause & Pachernegg

Birkhäuser, MH (2007). Editorial. Journal für Menopause (Ausgabe für die Schweiz), 14(1), pp. 4-5. Gablitz (A): Krause & Pachernegg

Crazzolara, SHC; Wunder, DM; Nägeli, E; Bodmer, C; Graf, S; Birkhäuser, MH (2007). Semen parameters in a fertile Swiss population. Swiss medical weekly(137), pp. 166-172. Muttenz: EMH Schweizerischer Ärzteverlag

Pines, A; Sturdee, D; Birkhäuser, MH; Gambacciani, M; Panay, N (2007). Empfehlungen zur postmenopausalen Hormontherapie. Gynäkologische Endokrinologie(1), pp. 18-20. Heidelberg: Springer-Medizin-Verlag

Pines, A; Sturdee, D; Birkhäuser, MH; Gambacciani, M; Panay, N (2007). Reccommandations sur le traitement hormonal lors de la post-ménopause. Gynäkologische Endokrinologie(1), pp. 21-23. Heidelberg: Springer-Medizin-Verlag

Pines, A; Sturdee, D; Birkhäuser, MH; Schneider, HP; Gambacciani M.Panay, N (2007). Reccommendations on postmenopausal hormone therapy. Climacteric, 10(3), pp. 181-194. Abingdon, UK: Informa Healthcare 10.1080/13697130701361657

Pines, A; Sturdee, D; Birkhäuser, M (2007). Press Statement Breast cancer and hormone therapy: a looking-glass mirror? Climacteric, 10(5), pp. 356-357. Abingdon, UK: Informa Healthcare 10.1080/13697130701607877

Pines, A; Sturdee, D; Birkhäuser, M (2007). Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisited. Climacteric, 10(3), pp. 195-196. Abingdon, UK: Informa Healthcare 10.1080/13697130701401073

Pines, A; Sturdee, D; Birkhäuser, M (2007). IMS reaction to recent breast cancer data. Climacteric, 10(1), pp. 9-10. Abingdon, UK: Informa Healthcare 10.1080/13697130601182989

Schwitter, J; Kozerke, S; Bremerich, J; Balters, C; Attenhofer, JC; Birkhäuser, MH; Bösiger, P; Buser, P (2007). Oral administration of 17Beta-Estradiol over 3 months without Progestin co-administration does not improve coronary flow reserve in postmenopausal women: a randomized placebo-controlled cross-over MR Study. Journal of cardiovascular magnetic resonance, 9(4), pp. 665-672. Philadelphia, Pa.: Taylor & Francis 10.1080/10976640601138730

Wunder, DM; Bersinger, NA; Yared, M; Kretschmer, R; Birkhäuser, MH (2007). Statistically significant changes of anti-mullerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertility and sterility, 89(4), pp. 927-933. New York, N.Y.: Elsevier 10.1016/j.fertnstert.2007.04.054

Tinneberg, HR; Birkhäuser, HM; Kuhl, K; Mueck, AO; Schaudig, K; Dierks, C (2007). Aktuelles zur Hormonersatztherapie. ComMed Update 2007

Bersinger, NA; Wunder, DM; birkhäuser, MH; Guibourdenche, J (2007). Measurement of anti-mullerian hormone by Beckman Coulter ELISA and DSL ELISA in assisted reproduction: differences between serum and follicular fluid. Clinica chimica acta, 384(1-2), pp. 174-175. Amsterdam: Elsevier 10.1016/j.cca.2007.05.011

2006

Wunder, D M; Yared, M; Bersinger, N A; Widmer, D; Kretschmer, R; Birkhäuser, M H (2006). Serum leptin and C-reactive protein levels in the physiological spontaneous menstrual cycle in reproductive age women. European journal of endocrinology, 155(1), pp. 137-42. Bristol: BioScientifica Ltd. 10.1530/eje.1.02178

Popp, Albrecht W E; Bodmer, Christine; Senn, Christoph; Fuchs, Gaby; Kraenzlin, Marius E; Wyss, H; Birkhaeuser, Martin H; Lippuner, Kurt (2006). Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy. Maturitas, 53(2), pp. 191-200. Amsterdam: Elsevier 10.1016/j.maturitas.2005.04.004

Bersinger, Nick A; Birkhäuser, Martin H; Wunder, Dorothea M (2006). Adiponectin as a marker of success in intracytoplasmic sperm injection/embryo transfer cycles. Gynecological endocrinology, 22(9), pp. 479-83. London: Informa Healthcare 10.1080/09537100600931316

Wunder, Dorothea M; Mueller, Michael D; Birkhäuser, Martin H; Bersinger, Nick A (2006). Increased ENA-78 in the follicular fluid of patients with endometriosis. Acta obstetricia et gynecologica Scandinavica, 85(3), pp. 336-42. Oxford: Wiley-Blackwell 10.1080/00016340500501715

Milsom, I; Lete, I; Bjertnaes, A; Rokstad, K; Lindh, I; Gruber, C J; Birkhäuser, M H; Aubeny, E; Knudsen, T; Bastianelli, C (2006). Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone. Human reproduction, 21(9), pp. 2304-11. Oxford: Oxford University Press 10.1093/humrep/del162

Birkhäuser, M; Braendle, W; Keller, P J; Kiesel, L; Kuhl, H; Neulen, J (2006). [Recommendations for hormonal contraception. 34. Workshop of the "Zurich Discussion Circle", April 2005]. Gynäkologisch-geburtshilfliche Rundschau, 46(1-2), pp. 58-63. Basel: Karger

Birkhäuser, M; Braendle, W; Keller, P J; Kiesel, L; Kuhl, H; Neulen, J (2006). [Recommendations for estrogen and progesterone replacement in climacteric and postmenopause. 33. Workshop of the "Zurich Discussion Circle", October 2004]. Gynäkologisch-geburtshilfliche Rundschau, 46(1-2), pp. 53-7. Basel: Karger

Koeferl Puorger, U P S; Buergin, M; Wunder, D; Crazzolara, S; Birkhaeuser, M H (2006). Surplus embryos in Switzerland in 2003: legislation and availability of human embryos for research. Reproductive biomedicine online, 13(6), pp. 772-7. Oxford: Elsevier 10.1016/S1472-6483(10)61023-1

Hugues, JN; Cédrin-Durnerin, I; Howles, CM; FSH, OI Study Group; Amram, M; Angelini, A; Balen, A; Barbereau, D; Birkhauser, M; Boujenah, A; De Leo, V; De Placido, G; Dessole, S; Favrin, S; Ferrazi, E; Gay, C; Germond, M; Hedon, B; Hocke, C; Jolly, C; ... (2006). The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO Group II anovulation: a prospective randomized multicentre study. Human reproduction, 21(11), pp. 2817-22. Oxford: Oxford University Press 10.1093/humrep/del265

Pines, A; Sturdee, DW; Birkhäuser, M; International, Menopause Society (2006). WHI and breast cancer: a response to a recent publication from the WHI. Climacteric, 9(4), p. 244. Abingdon, UK: Informa Healthcare 10.1080/13697130600865790

Pines, A; Sturdee, DW; Birkhäuser, M; International, Menopause Society (2006). More data on hormone therapy and coronary artery disease: comments on recent publications from the WHI and Nurses' Study. Climacteric, 9(2), pp. 75-6. Abingdon, UK: Informa Healthcare 10.1080/13697130600655415

Birkhäuser, MH (2006). Die klinische Bedeutung von Gestagen-Partialwirkungen Gynäkologischer Endokrinologie. Gynecological endocrinology(4), pp. 42-64. London: Informa Healthcare

Birkhäuser, MH (2006). Differenzierte HRT - wo stehen wir heute? Journal für Menopause (Ausgabe für die Schweiz), pp. 1-23. Gablitz (A): Krause & Pachernegg

Birkhäuser, MH (2006). Hormonersatztherapie nach WHI and Million Women Study. Gynäkologie + Geburtshilfe, pp. 41-42. Heidelberg: Springer-Medizin-Verlag

Pines, A; Sturdee, D; Birkhäuser, MH (2006). Hormonersatztherapie - Stellungnahme der Internationalen Menopausengesellschaft. Journal für Menopause (Ausgabe für die Schweiz)(1), pp. 21-22. Gablitz (A): Krause & Pachernegg

Stevenson, JC; Birkhäuser, MH; Burger, H; Brincat, M; Gaspard, U (2006). EMEA and Osteoporosis. Human reproduction(21), pp. 1668-1671. Oxford: Oxford University Press

2005

Birkhäuser, MH (2005). Was bedeuten die Resultate der Women's-Health-Initiative zur Hormonersatztherapie für die tägliche klinische Arbeit? Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS(5), pp. 379-388. Basel: EMH Editores Medicorum Helveticorum

Provide Feedback